Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.CHMP issues positive opinion on CYT387
Earlier, the company has received orphan drug status for CYT387 for the treatment of myelofibrosis from the US Food and Drug Administration (FDA). YM BioSciences president and CEO
Earlier, the company has received orphan drug status for CYT387 for the treatment of myelofibrosis from the US Food and Drug Administration (FDA). YM BioSciences president and CEO
As per the terms of its license agreement with Rhode Island Hospital, MultiCell Technologies is the worldwide exclusive licensee of US patent 7,935,528. The patent covers the methods
The patent entitled, ‘Topical pharmaceutical composition comprising a cholinergic agent or a calcium channel blocker" is still pending. Ventrus chairman and CEO Russell Ellison said this is a
Both the companies also signed a supply agreement with minimum purchase volumes which was scheduled over several years. According to Tecan, upon successful completion of development the sales
The project will be initiated in Q3 2011 and run for three years. The grant will cover up to 35% of the project costs. PCI Biotech is developing
Connell Brothers serves as a supplier and customers in industries, including animal feed, lube oils, adhesives, water treatment, textiles, ceramics, construction, food and beverage, personal care, rubber and
The company has reported net profit of INR430m, compared to INR590m during the same period last year. For FY 2010-11, sales increased 16% to INR21.61bn compared with INR18.67bn
The company has earned net profit of INR4.43bn, resulting into a net margin of 30%. The company has posted net sales of INR57.21bn for the financial year ended
The study evaluated NCX 226, in comparison with bosentan, in a preclinical model of pulmonary fibrosis induced by bleomycin. The results of the trial suggested that NCX 226
The Solesta gel is injected into a layer of tissue beneath the anus lining and may help build tissue in that area. The FDA approval was given on